PeptadexPEPTADEX
Back to Library

Fragment 176-191

Also known as: HGH Fragment 176-191, HGH Frag, AOD-9604 precursor

Growth HormonePRECLINICAL

Clinical Status

Preclinical — research compound for fat metabolism.

Mechanism of Action

The lipolytic fragment of human growth hormone (amino acids 176-191). Stimulates lipolysis and inhibits lipogenesis without affecting IGF-1 levels, blood glucose, or promoting tissue growth.

Dosing Defaults

Dose

250-500 mcg

Frequency

1-2x daily

Administration

Subcutaneous injection

Timing

Morning (fasted) or pre-exercise

Food

fasted

Duration

8-12 weeks

Dose range: 200-600 mcg per dose

Fasted state required. Pre-exercise timing enhances lipolytic effects.

Side Effects

  • •Injection site reactions
  • •Mild headache
  • •Drowsiness
  • •Numbness at injection site

Contraindications & Warnings

  • ⚠Active malignancy
  • •Not medical advice

Compare

Compare Fragment 176-191 with another peptide side-by-side.

Calculate Dose

Use the reconstitution calculator to prepare your Fragment 176-191 dose.

Open Calculator

Ad

Related Growth Hormone Peptides

Ipamorelin

PHASE 2
Growth Hormone

Selective GH secretagogue. Considered one of the safest GHRPs.

CJC-1295

PHASE 2
Growth Hormone

Synthetic GHRH analog that stimulates GH release from the pituitary.

CJC-1295 DAC

PHASE 2
Growth Hormone

Long-acting version of CJC-1295 with extended half-life via albumin binding.

Tesamorelin

FDA APPROVED
Growth Hormone

FDA-approved GHRH analog for visceral fat reduction in HIV lipodystrophy.

This information is for educational purposes only and is not medical advice. Dosing data is based on research literature and community reports. Always consult a qualified healthcare provider before using any peptide.